Replies to post #3340 on Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[carl_52fl]

The share price must definitely rise to make any plans for the NASDAQ. But the plan can be straight-forward. First of all, as "Long" says, exposure is the key. With exposure, and a good quarter or two, GTEC can earn its proper PE of 15 to 20. Then with the original proposal from the merger agreement of a 7-1 reverse split, the stock price should meet NASDAQ requirements.

There is one hurdle, that can't be overlooked, standing in the way. Another part of the merger agreement was that GTEC was to receive $30M in equity financing, which basically means dilution at a discounted price. So far Pope has bought 20M shares at 0.25 and 10M shares at 0.32. At the time of this investment, this price was at a discount, but now you see the share price hovering at 0.25.

Now, by merger agreement, $21.8M of equity financing is still required. I don't know if there is a time frame on this or not. We, as shareholders, hope that this occurs after a few solid quarters and at a much higher share price. If it occurs at 0.32, then we're stuck here for a while.

Carl